Skip to content
2000
Volume 7, Issue 1
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

This mini-review will provide an overview on the recent design principles and structure-activity-relationship of β-selective thyroid hormone receptor (TR) agonists. The prospects for the treatment of metabolic diseases as dyslipidemia with TRβ-selective ligands are considerable enough so as to avoid cardiovascular acceleration mediated through TRα.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/138955707779317885
2007-01-01
2024-11-14
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/138955707779317885
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test